Fecal calprotectin as a predictor of histological remission in patients with ulcerative colitis treated with vedolizumab: A retrospective cohort study

被引：0
|
作者：
Rubtsov, D. [1 ]
Ramaswamy, P. Kakkadasam [1 ]
Mohsen, W. [1 ]
机构：
[1] Gold Coast Univ Hosp, Gold Coast, Qld, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
66
引用
收藏
页码：104 / 104
页数：1
相关论文
共 50 条
  • [21] Serial semi-quantitative measurement of fecal calprotectin in patients with ulcerative colitis in remission
    Garcia-Planella, Esther
    Manosa, Miriam
    Chaparro, Maria
    Beltran, Belen
    Barreiro-de-Acosta, Manuel
    Gordillo, Jordi
    Ricart, Elena
    Bermejo, Fernando
    Garcia-Sanchez, Valle
    Piqueras, Marta
    Llao, Jordina
    Gisbert, Javier P.
    Cabre, Eduard
    Domenech, Eugeni
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2018, 53 (02) : 152 - 157
  • [22] PROGNOSTIC VALUE OF FECAL CALPROTECTIN IN BIOLOGIC-TREATED PATIENTS WITH ULCERATIVE COLITIS
    Dulai, Parambir S.
    Feagan, Brian G.
    Sands, Bruce E.
    Chen, Jingjing
    Lasch, Karen
    Lirio, Richard A.
    GASTROENTEROLOGY, 2021, 160 (06) : S46 - S47
  • [23] Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative Colitis
    Theede, Klaus
    Holck, Susanne
    Ibsen, Per
    Kallemose, Thomas
    Nordgaard-Lassen, Inge
    Nielsen, Anette Mertz
    INFLAMMATORY BOWEL DISEASES, 2016, 22 (05) : 1042 - 1048
  • [24] Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease
    Zittan, Eran
    Kelly, Orlaith B.
    Kirsch, Richard
    Milgrom, Raquel
    Burns, Jane
    Nguyen, Geoffrey C.
    Croitoru, Ken
    Van Assche, Gert
    Silverberg, Mark S.
    Steinhart, A. Hillary
    INFLAMMATORY BOWEL DISEASES, 2016, 22 (03) : 623 - 630
  • [25] Low Fecal Calprotectin Correlates With Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease
    Zittan, Eran
    Kelly, Orlaith
    Kirsch, Richard
    Burns, Jane
    Stempak, Joanne M.
    Nguyen, Geoffrey C.
    Van Assche, Gert A.
    Croitoru, Kenneth
    Silverberg, Mark S.
    Steinhart, A. Hillary
    GASTROENTEROLOGY, 2015, 148 (04) : S441 - S441
  • [26] Vedolizumab Induces Clinical Response and Remission Across a Range of Baseline Fecal Calprotectin Levels in Patients with Ulcerative Colitis: Results from GEMINI 1
    Wyant, Tim
    Lewis, James
    Reinisch, Walter
    Dassopoulos, Emistocles
    Ginsburg, Philip
    Sands, Bruce
    Feagan, Brian
    Danese, Silvio
    Roseth, Arne
    Rosario, Maria
    Yang, Huyuan
    Parikh, Asit
    Bressler, Brian
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S486 - S486
  • [27] Faecal calprotectin is an early predictor of endoscopic response and histological remission after the start of vedolizumab
    Pauwels, R. W. M.
    de Vries, A. C.
    Goet, J. C.
    Erler, N. S.
    van der Woude, C. J.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S285 - S286
  • [28] Fecal Calprotectin Evaluation in Patients with Ulcerative Colitis Reply
    Burri, Emanuel
    Beglinger, Christoph
    Lehmann, Frank Serge
    von Felten, Stefanie
    DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (04) : 1109 - 1110
  • [29] Mesalazine dose modification based on fecal calprotectin levels in ulcerative colitis patients in clinical remission
    Pinero, G. S.
    Manosa, M.
    Canete, F.
    Calafat, M.
    Gonzalez, L.
    Ruffinengo, O.
    Domenech, E.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 557 - 558
  • [30] Fecal Level of Calprotectin Identifies Histologic Inflammation in Patients With Ulcerative Colitis in Clinical and Endoscopic Remission
    Guardiola, Jordi
    Lobaton, Triana
    Rodriguez-Alonso, Lorena
    Ruiz-Cerulla, Alexandra
    Arajol, Claudia
    Loayza, Carolina
    Sanjuan, Xavier
    Sanchez, Elena
    Rodriguez-Moranta, Francisco
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (11) : 1865 - 1870
12345